位置：成果数据库 > 期刊 > 期刊详情页
纳米量子点标记探针技术对乳腺癌人表皮生长因子受体2及IV型胶原蛋白的原位标记成像及临床意义
  • 期刊名称：中华普通外科杂志
  • 时间：2014.9.30
  • 页码：728-732
  • 相关项目：量子点标记探针技术的乳腺癌关键分子成像体系与个体化预警新方法
作者： 马婕,孙圣荣,陈创,孙金中,涂毅,方敏,李雁|
同期刊论文项目
量子点标记探针技术的乳腺癌关键分子成像体系与个体化预警新方法
期刊论文 18
同项目期刊论文
Ki-67在人类表皮细胞生长因子受体-2阳性乳腺浸润性导管癌中的表达和意义
乳腺癌组织中Ki-67的临床研究进展
Relationships and indications of Ki67 expression with clinicopathologicparameters and molecular subt
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-p
Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlat
Computer-Based Image Studies on Tumor Nests Mathematical Features of Breast Cancer and Their Clinica
CC类趋化因子5和基质金属蛋白酶-9的定量检测及临床意义
A Clinical Database of Breast Cancer Patients Reveals Distinctive Clinico-pathological Characteristi
Quantum dots-based tissue and in vivo imaging in breast cancerresearches: current status and future
Clinical pathological characteristics of breast cancer patients withsecondary diabetes after systemi
Quantum dot-based in situ simultaneous molecular imaging andquantitative analysis of EGFR and collag
Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positiv
Quantum dots-based quantitative and in situ multiple imaging on ki67 andcytokeratin to improve ki67
纳米量子点标记探针技术对乳腺癌人表皮生长因子受体2及Ⅳ型胶原蛋白的原位标记成像及临床意义
乳腺导管原位癌、微浸润癌及浸润性癌临床病理指标表达差异分析